134 related articles for article (PubMed ID: 36192583)
1. Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer.
Krus I; Brynychová V; Hlaváč V; Václavíková R; Kováčová M; Koževnikovová R; Kopečková K; Tornikidis J; Vrána D; Gatěk J; Souček P
Mol Diagn Ther; 2022 Nov; 26(6):665-678. PubMed ID: 36192583
[TBL] [Abstract][Full Text] [Related]
2. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
4. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer.
Corson TW; Gallie BL
Int J Cancer; 2006 Sep; 119(5):1088-94. PubMed ID: 16570270
[TBL] [Abstract][Full Text] [Related]
5. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer.
Neska-Długosz I; Buchholz K; Durślewicz J; Gagat M; Grzanka D; Tojek K; Klimaszewska-Wiśniewska A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575892
[TBL] [Abstract][Full Text] [Related]
7. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.
Corson TW; Zhu CQ; Lau SK; Shepherd FA; Tsao MS; Gallie BL
Clin Cancer Res; 2007 Jun; 13(11):3229-34. PubMed ID: 17545527
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
9. Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma.
Wang H; Tang F; Tang P; Zhang L; Gan Q; Li Y
Aging (Albany NY); 2022 Oct; 14(19):8013-8031. PubMed ID: 36227151
[TBL] [Abstract][Full Text] [Related]
10. High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer.
Qiu HL; Deng SZ; Li C; Tian ZN; Song XQ; Yao GD; Geng JS
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):239-245. PubMed ID: 28165566
[TBL] [Abstract][Full Text] [Related]
11. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.
Singel SM; Cornelius C; Zaganjor E; Batten K; Sarode VR; Buckley DL; Peng Y; John GB; Li HC; Sadeghi N; Wright WE; Lum L; Corson TW; Shay JW
Neoplasia; 2014 Mar; 16(3):247-56, 256.e2. PubMed ID: 24784001
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer.
Wang W; Shi Y; Li J; Cui W; Yang B
Biosci Rep; 2016; 36(2):. PubMed ID: 27128470
[TBL] [Abstract][Full Text] [Related]
13. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
14. Loss-of-function mutations in KIF14 cause severe microcephaly and kidney development defects in humans and zebrafish.
Reilly ML; Stokman MF; Magry V; Jeanpierre C; Alves M; Paydar M; Hellinga J; Delous M; Pouly D; Failler M; Martinovic J; Loeuillet L; Leroy B; Tantau J; Roume J; Gregory-Evans CY; Shan X; Filges I; Allingham JS; Kwok BH; Saunier S; Giles RH; Benmerah A
Hum Mol Genet; 2019 Mar; 28(5):778-795. PubMed ID: 30388224
[TBL] [Abstract][Full Text] [Related]
15. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
Corson TW; Huang A; Tsao MS; Gallie BL
Oncogene; 2005 Jul; 24(30):4741-53. PubMed ID: 15897902
[TBL] [Abstract][Full Text] [Related]
16. SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma.
Hlavac V; Vaclavikova R; Brynychova V; Dvorak P; Elsnerova K; Kozevnikovova R; Raus K; Kopeckova K; Mestakova S; Vrana D; Gatek J; Soucek P
Mol Diagn Ther; 2021 Jan; 25(1):99-110. PubMed ID: 33387348
[TBL] [Abstract][Full Text] [Related]
17. SNP rs10800708 within the KIF14 miRNA binding site is linked with breast cancer.
Shasttiri A; Rostamian Delavar M; Baghi M; Dehghani Ashkezari M; Ghaedi K
Br J Biomed Sci; 2019 Jan; 76(1):46-48. PubMed ID: 30092718
[No Abstract] [Full Text] [Related]
18. The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma.
Hung PF; Hong TM; Hsu YC; Chen HY; Chang YL; Wu CT; Chang GC; Jou YS; Pan SH; Yang PC
PLoS One; 2013; 8(4):e61664. PubMed ID: 23626713
[TBL] [Abstract][Full Text] [Related]
19. The pan-cancer landscape of prognostic germline variants in 10,582 patients.
Chatrath A; Przanowska R; Kiran S; Su Z; Saha S; Wilson B; Tsunematsu T; Ahn JH; Lee KY; Paulsen T; Sobierajska E; Kiran M; Tang X; Li T; Kumar P; Ratan A; Dutta A
Genome Med; 2020 Feb; 12(1):15. PubMed ID: 32066500
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of cytokinesis regulators
Hanicinec V; Brynychova V; Rosendorf J; Palek R; Liska V; Oliverius M; Kala Z; Mohelnikova-Duchonova B; Krus I; Soucek P
Oncol Lett; 2021 Aug; 22(2):598. PubMed ID: 34188700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
